Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8+ T cells.

Osborn JF, Mooster JL, Hobbs SJ, Munks MW, Barry C, Harty JT, Hill AB, Nolz JC.

Sci Immunol. 2017 Oct 13;2(16). pii: eaan6049. doi: 10.1126/sciimmunol.aan6049.

2.

The domestic cat antibody response to feline herpesvirus-1 increases with age.

Munks MW, Montoya AM, Pywell CM, Talmage G, Forssen A, Campbell TL, Dodge DD, Kappler JW, Marrack P.

Vet Immunol Immunopathol. 2017 Jun;188:65-70. doi: 10.1016/j.vetimm.2017.05.002. Epub 2017 May 4.

PMID:
28615129
3.

Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.

Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB.

J Exp Med. 2017 Jul 3;214(7):1889-1899. doi: 10.1084/jem.20161988. Epub 2017 May 31.

4.

Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.

Clapp T, Munks MW, Trivedi R, Kompella UB, Braun LJ.

Vaccine. 2014 Jun 24;32(30):3765-71. doi: 10.1016/j.vaccine.2014.05.037. Epub 2014 May 20.

PMID:
24856785
5.

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.

McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1122-31. doi: 10.1073/pnas.1300392110. Epub 2013 Feb 27.

6.

Progress in development of immunocontraceptive vaccines for permanent non-surgical sterilization of cats and dogs.

Munks MW.

Reprod Domest Anim. 2012 Aug;47 Suppl 4:223-7. doi: 10.1111/j.1439-0531.2012.02079.x. Review.

PMID:
22827374
7.

Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection.

Schlub TE, Sun JC, Walton SM, Robbins SH, Pinto AK, Munks MW, Hill AB, Brossay L, Oxenius A, Davenport MP.

J Immunol. 2011 Aug 1;187(3):1385-92. doi: 10.4049/jimmunol.1100416. Epub 2011 Jun 22.

8.

Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo.

Munks MW, McKee AS, Macleod MK, Powell RL, Degen JL, Reisdorph NA, Kappler JW, Marrack P.

Blood. 2010 Dec 9;116(24):5191-9. doi: 10.1182/blood-2010-03-275529. Epub 2010 Sep 27.

9.

Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P.

J Immunol. 2009 Oct 1;183(7):4403-14. doi: 10.4049/jimmunol.0900164. Epub 2009 Sep 4.

10.

Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.

Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, Babic M, Hill AB, Koszinowski UH, Jonjic S, Lanier LL, Vidal SM.

J Exp Med. 2009 Mar 16;206(3):515-23. doi: 10.1084/jem.20080954. Epub 2009 Mar 2.

11.

Towards an understanding of the adjuvant action of aluminium.

Marrack P, McKee AS, Munks MW.

Nat Rev Immunol. 2009 Apr;9(4):287-93. doi: 10.1038/nri2510.

12.

The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection.

Walton SM, Wyrsch P, Munks MW, Zimmermann A, Hengel H, Hill AB, Oxenius A.

J Immunol. 2008 Jul 15;181(2):1128-34.

13.

Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

Holtappels R, Simon CO, Munks MW, Thomas D, Deegen P, Kühnapfel B, Däubner T, Emde SF, Podlech J, Grzimek NK, Oehrlein-Karpi SA, Hill AB, Reddehase MJ.

J Virol. 2008 Jun;82(12):5781-96. doi: 10.1128/JVI.00155-08. Epub 2008 Mar 26.

14.

How do adjuvants work? Important considerations for new generation adjuvants.

McKee AS, Munks MW, Marrack P.

Immunity. 2007 Nov;27(5):687-90. Review.

15.

OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism.

Humphreys IR, Loewendorf A, de Trez C, Schneider K, Benedict CA, Munks MW, Ware CF, Croft M.

J Immunol. 2007 Aug 15;179(4):2195-202.

16.
18.

CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection.

Hokeness KL, Deweerd ES, Munks MW, Lewis CA, Gladue RP, Salazar-Mather TP.

J Virol. 2007 Feb;81(3):1241-50. Epub 2006 Nov 15.

19.

Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis.

Pinto AK, Munks MW, Koszinowski UH, Hill AB.

J Immunol. 2006 Sep 1;177(5):3225-34.

20.

Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.

Munks MW, Cho KS, Pinto AK, Sierro S, Klenerman P, Hill AB.

J Immunol. 2006 Jul 1;177(1):450-8.

21.

Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus.

Munks MW, Gold MC, Zajac AL, Doom CM, Morello CS, Spector DH, Hill AB.

J Immunol. 2006 Mar 15;176(6):3760-6.

22.

4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.

Munks MW, Mourich DV, Mittler RS, Weinberg AD, Hill AB.

Immunology. 2004 Aug;112(4):559-66.

23.

Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response.

Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB.

J Immunol. 2004 Jun 1;172(11):6944-53.

24.

Spermine compaction is an efficient and economical method of producing vaccination-grade DNA.

Mourich DV, Munks MW, Murphy JC, Willson RC, Hill AB.

J Immunol Methods. 2003 Mar 1;274(1-2):257-64.

PMID:
12609551
26.
27.

Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.

Evans DE, Munks MW, Purkerson JM, Parker DC.

J Immunol. 2000 Jan 15;164(2):688-97.

Supplemental Content

Loading ...
Support Center